Titre:
  • IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
Auteur:Clappier, E; Grardel, Nathalie; Bakkus, M; Rapion, J; De Moerloose, B; Kastner, Philippe; Caye, A; Vivent, Jocelyne; Costa, V; Ferster, Alina; Lutz, P; Mazingue, F; Millot, Frédéric; Plantaz, D; Plat, G; Plouvier, Emmanuel; Poirée, Marilyne; Sirvent, Nicolas; Uyttebroeck, A; Yakouben, Karima; Girard, S; Dastugue, N; Suciu, S; Benoît, Yves; Bertrand, Yves; Cavé, H; Children’s Leukemia Group (CLG) of the European Organisation for Research and Treatment of Cancer (EORTC),
Informations sur la publication:Leukemia, 29, 11, page (2154-2161)
Statut de publication:Publié, 2015-11
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adolescent
Child
Child, Preschool
Female
Gene Deletion
Humans
Ikaros Transcription Factor -- genetics
Infant
Male
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy -- genetics -- mortality
Prognosis
Recurrence
Langue:Anglais
Identificateurs:urn:issn:0887-6924
info:doi/10.1038/leu.2015.134
info:pii/leu2015134
info:pmid/26050650